GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
5.7k
c/retatrutide·posted 11 months ago by u/discount_math_dm

is it normal to get nausea at week 65

Discussion Well Actually ×7 Cold Box ×2 Long Haul ×3

Been lurking in c/sideeffects for about 10 months and finally have something worth posting.

Short version: week 67, 15mg, and triple agonist is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 25 threads, and the answers split roughly down the middle.

What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 73.

8,780 up / 3,100 down74% upvoted40 commentsid 1nzzjb12 Aug 2025

40 comments

6 in this archive, depth 3

best — the order this archive was captured in

u/nordic_pricing361 points·11 months ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

replysharereportpermalink
u/anya_moreau0 points·11 months ago

The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.

replysharereportpermalink
u/quiet_moderatormod1 point·11 months ago

phase 2 numbers are not maintenance numbers, cite the trial

replysharereportpermalink
u/burned_once_twice116 points·11 months ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
load more comments (1) →
u/andres_sorensen-22 points·11 months ago

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.